Authors: CHALLETON C BRANEA F SCHLUMBERGER M GAILLARD N DEVATHAIRE F BADIE C ANTONINI P PARMENTIER C

Citation: C. Challeton et al., CHARACTERIZATION AND RADIOSENSITIVITY AT HIGH OR LOW-DOSE RATE OF 4 CELL-LINES DERIVED FROM HUMAN THYROID-TUMORS, International journal of radiation oncology, biology, physics, 37(1), 1997, pp. 163-169

Authors: DEVATHAIRE F SCHLUMBERGER M DELISLE MJ FRANCESE C CHALLETON C DELAGENARDIERE E MEUNIER F PARMENTIER C HILL C SANCHOGARNIER H

Citation: F. Devathaire et al., LEUKEMIAS AND CANCERS FOLLOWING I-131 ADMINISTRATION FOR THYROID-CANCER, British Journal of Cancer, 75(5), 1997, pp. 734-739

Authors: SCHLUMBERGER M CHALLETON C DEVATHAIRE F TRAVAGLI JP GARDET P LUMBROSO JD FRANCESE C FONTAINE F RICARD M PARMENTIER C

Citation: M. Schlumberger et al., RADIOACTIVE IODINE TREATMENT AND EXTERNAL RADIOTHERAPY FOR LUNG AND BONE METASTASES FROM THYROID-CARCINOMA, The Journal of nuclear medicine, 37(4), 1996, pp. 598-605

Authors: CHALLETON C BOUNACER A DUVILLARD JA CAILLOU B DEVATHAIRE F MONIER R SCHLUMBERGER M SUAREZ HG

Citation: C. Challeton et al., PATTERN OF RAS AND GSP ONCOGENE MUTATIONS IN RADIATION-ASSOCIATED HUMAN THYROID-TUMORS, Oncogene, 11(3), 1995, pp. 601-603

Authors: SCHLUMBERGER M CHALLETON C DEVATHAIRE F PARMENTIER C

Citation: M. Schlumberger et al., TREATMENT OF DISTANT METASTASES OF DIFFERENTIATED THYROID-CARCINOMA, Journal of endocrinological investigation, 18(2), 1995, pp. 170-172